Oriin Biology (688319.SH) is planning to issue H-shares stocks and list on the Hong Kong Stock Exchange.

Zh tng cijng APP xn, uln shngw (688319.SH) fb gnggo, gngs wi shnghu gngs gujhu zhnlu bzh, tgo guj zhmngd y yngxingl, bng jn yb yuhu zbn jigu, zngqing zngh jngzhng shl, zhngzi chupn fxng jngwi gfn (H g) bng shnqng zi xinggng linh jioy su yuxin gngs (jinchng "xinggng linjio su") gupin shngsh shm. Financial news app, Orin Biotech (688319.SH) announced that the company is planning to issue overseas shares (H shares) and apply for listing on the Hong Kong Stock Exchange (referred to as "Hong Kong Stock Exchange") in order to deepen the company's international strategy layout, enhance international visibility and influence, further optimize capital structure, and strengthen overall competitive strength.